Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AEC Amersham is a leading supplier of specialized products and services to the healthcare, life sciences, and industrial sectors in sub-Saharan Africa. Originally established as a joint venture between the South African Atomic Energy Corporation (AEC) and Amersham International (UK), the company provides a comprehensive range of radiopharmaceuticals, laboratory equipment, and diagnostic kits. Their healthcare portfolio focuses on nuclear medicine, oncology, and radiology, while their life sciences division supports research with high-quality reagents and instrumentation. The company operates as a critical link in the regional supply chain, offering technical support, maintenance, and training alongside its product distribution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AEC Amersham SOC.